PhRMA defines chutzpah

(PhRMA) president and CEO Stephen J. Ubl issued the following statement on President Donald Trump’s drug pricing blueprint: “These far-reaching proposals could fundamentally change how patients access medicines and realign incentives across the entire prescription drug supply chain. While some of these proposals could help make medicines more affordable for patients, others would disrupt coverage and limit patients’ access to innovative treatments”. Folks, that is chutzpah. Continue reading

Novartis’s PR nightmare

KEY SUMMARY: “Any formal lobbying by companies of Congress or Cabinet agencies must be reported and disclosed quarterly. Novartis’s outreach to Cohen — who isn’t part of the administration, isn’t a registered lobbyist and isn’t an expert in the telecommunications or pharmaceutical industriesfalls into a secretive, gray area of influence activity that ethics experts charge is ripe for abuse.” Continue reading

Medical device the rule of thumb seems to be luck over science

KEY IDEA:  Seventy million Americans have a medical device implanted within their body. “When it comes to medical devices, we built a system that doesn’t work,” David Kessler, the former FDA commissioner, said in The Bleeding Edge.  The disturbing truth is that, despite so many people relying on such implants, the medical device industry is very weakly regulated. Continue reading